Jennewein and Yili sign MoU to develop innovative infant formula
date:Feb 20, 2019
ral or healthy microbiome may potentially lead to obesity, autism or allergy development in addition to other existing issues in infant health and development. However, most infant formulas do not
contain HMOs, as of today.

Dr Gerrit Smit, managing director of Yili Innovation Center Europe, stated: Yili Group has been dedicated to Chinese breast milk composition studies for years and has initiated the establishment of a Chinese Breast Milk Database. Yili has constantly brought innovative produc
4/5 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
04/19 04:51